essential drugs; price increases; limits
Arizona bill caps price increases on essential drugs to improve medication affordability, but faces legal and market-feasibility challenges.
Arizona bill caps price increases on essential drugs to improve medication affordability, but faces legal and market-feasibility challenges.
HB 2645 proposes to limit price increases on essential drugs in Arizona by establishing caps or restrictions on how much pharmaceutical manufacturers can raise prices year-over-year. The bill aims to make critical medications more affordable for Arizona residents by preventing excessive pricing practices on drugs deemed essential to public health.
Drug pricing significantly impacts healthcare affordability and patient access to life-saving medications. Without price controls, patients often face impossible choices between purchasing prescribed medications and meeting other basic needs, while state healthcare budgets face strain from rising pharmaceutical costs.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.